Literature DB >> 3336546

Oxytocin augmentation of labor: a comparison of 15- and 30-minute dose increment intervals.

T C Foster1, J D Jacobson, G J Valenzuela.   

Abstract

Two different regimens for oxytocin augmentation of labor were compared retrospectively in two institutions. In one regimen, the interval between dose increments was 15 minutes; in the other it was 30 minutes. All study patients were nulliparous and had uncomplicated pregnancies in spontaneous active labor; the 15-minute group consisted of 92 patients and the 30-minute group had 82 patients. No differences were demonstrated in age, dilation when oxytocin administration started, length of oxytocin administration, cesarean section rate, complications of delivery, birth weight, or Apgar scores. The maximal oxytocin dose in the 30-minute interval group was significantly lower. This group also had the oxytocin infusion stopped for evidence of uterine hyperstimulation and/or abnormal fetal heart rate tracing significantly less often (6.9% for the 30-minute interval versus 17.8% for the 15-minute interval; P = .0017). Overall, these results suggest that the longer interval does not increase the length of labor but decreases the incidence of uterine hyperstimulation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3336546

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  3 in total

1.  Labor induction and augmentation with oxytocin: pharmacokinetic considerations.

Authors:  M Gonser
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

2.  Oxytocin and the augmentation of labor : Human and medical perspectives.

Authors:  P Curtis
Journal:  Hum Nat       Date:  1993-12

Review 3.  How much synthetic oxytocin is infused during labour? A review and analysis of regimens used in 12 countries.

Authors:  Deirdre Daly; Karin C S Minnie; Alwiena Blignaut; Ellen Blix; Anne Britt Vika Nilsen; Anna Dencker; Katrien Beeckman; Mechthild M Gross; Jessica Pehlke-Milde; Susanne Grylka-Baeschlin; Martina Koenig-Bachmann; Jette Aaroe Clausen; Eleni Hadjigeorgiou; Sandra Morano; Laura Iannuzzi; Barbara Baranowska; Iwona Kiersnowska; Kerstin Uvnäs-Moberg
Journal:  PLoS One       Date:  2020-07-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.